Production of COVID Vaccine Abruptly Shuts Down

Drug maker Johnson & Johnson has shut down the sole factory that was making its coronavirus vaccine, according to a news report, making African nations worry that they will pay the price for the company’s decision to use the plant for a different vaccine that could position J&J to reap huge profits in the future.

Citing sources it identified as “people familiar with the decision,” The New York Times reported this week that Johnson & Johnson had temporarily halted production of the COVID-19 vaccine to make “an experimental but potentially more profitable vaccine to protect against an unrelated virus.”

The move “blindsided” two major customers for the vaccine, the Times reported: The African Union, which represents 55 countries on the continent, and Covax, an international group that distributes COVID-19 vaccines.

The post Production of COVID Vaccine Abruptly Shuts Down appeared first on Populist Press ©2022.